FINWIRES · TerminalLIVE
FINWIRES

澳洲股市持平;Suncorp集團達成24億澳幣再保險交易

-- 週五收盤時,澳洲股市走勢平穩,略偏下跌,原因是市場面臨不確定性,而美伊在中東的僵局仍在持續。 S&P/ASX 200 指數變化不大,收在 8,786.50 點。 布蘭特原油期貨上漲 1.2%,至每桶 106.3 美元。霍爾木茲海峽繼續關閉,美國稱已對一艘與伊朗有關的油輪進行了「海上攔截」。 美國總統川普下令海軍「擊落」在霍爾木茲海峽布雷的伊朗船隻。 在國內方面,根據澳新銀行 (ANZ) 的一份報告,澳洲經調整後的平均通膨率在今年第一季環比上漲 0.9%,年比上漲 3.6%,符合預期。該銀行預計,消費者物價通膨率季增1.4%,年增4.1%。 報告補充道,整體通膨率與經調整後的平均通膨率之間的差異,部分反映了3月份燃油價格上漲的影響。 公司新聞方面,Suncorp集團(ASX:SUN)達成了一項再保險協議,每年可獲得8億澳元的保障,在協議五年期限內,總保障額最高可達24億澳元。該協議於6月30日生效,其中包括Suncorp現有下放安排提供的低於3.5億澳元的保障。其股價在收盤時上漲超過4%。 Newmont(ASX:NEM)公佈第一季調整後每股收益為2.90澳元,高於去年同期的1.25澳元。截至3月31日的三個月內,銷售額達到73.1億澳元,去年同期為50.1億澳元。其股價收盤上漲1%。最後,福特斯克(ASX:FMG)公佈,截至3月31日的第三季度,鐵礦石總出貨量為4,840萬個濕公噸(wmt)。該公司2025年同期(截至3月31日)的鐵礦石出貨量為4,610萬個濕公噸。其股價在收盤時下跌超過5%。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB